Denis R. Burger

Executive Chairman at Biocide, Inc.

Denis R. Burger

Denis R. Burger

Executive Chairman at Biocide, Inc.

Overview
Career Highlights

Yamhill Valley Vineyards, Inc.
Biocide, Inc.
BioCurex, Inc.

RelSci Relationships

342

Number of Boards

15

Birthday

1944

Age

77

Relationships
RelSci Relationships are individuals Denis R. Burger likely has professional access to. A relationship does not necessarily indicate a personal connection.

Executive Director at Trinity Biotech Plc

Relationship likelihood: Strong

Executive Chairman at Surface Logix LLC

Relationship likelihood: Strong

Co-Founder at Trinity Biotech Plc

Relationship likelihood: Strong

Chairman of the Board, President & Chief Executive Officer at Aptose Biosciences, Inc.

Relationship likelihood: Strong

Benefit Plan Administrator at University of Portland

Relationship likelihood: Strong

Director & Co-Founder at Yamhill Valley Vineyards, Inc.

Relationship likelihood: Strong

Founder & Chief Technology Officer at Ames Technology Inc.

Relationship likelihood: Strong

Founder at 13 Therapeutics

Relationship likelihood: Strong

Chief Executive Officer at Paulson Investment Co. LLC

Relationship likelihood: Strong

President & Chief Executive Officer at VBI Vaccines, Inc.

Relationship likelihood: Strong

Paths to Denis R. Burger
Potential Connections via
Relationship Science
You
Denis R. Burger
Executive Chairman at Biocide, Inc.
Education
Master of Science in Microbiology & Immunology
Class of 1969

Established in 1885, the University of Arizona, the state's super land-grant university with two medical schools, produces graduates who are real-world ready through its 100% Engagement initiative. Recognized as a global leader, the UA is also a leader in research, bringing more than $606 million in research investment each year, and ranking 20th among all public universities. The UA is advancing the frontiers of interdisciplinary scholarship and entrepreneurial partnerships, and is a member of the Association of American Universities, the 62 leading public and private research universities. It benefits the state with an estimated economic impact of $8.3 billion annually.

B.A. Degree in Bacteriology & Immunology
Class of 1965

University of California Berkeley National rankings: In a National Research Council analysis of 212 doctoral programs at American universities, 48 Berkeley programs place among the top 10 nationwide. Faculty awards and honors: There are 8 Nobel Laureates, 32 MacArthur Fellows, and 4 Pulitzer Prize winners among the current faculty. History of UC Berkeley: Historical highlights, arranged by topic, following the campus's development — from UC's founding in 1868 to a turn-of-the-century building boom, a research explosion in the 1930s, the Free Speech Movement of the '60s, and Berkeley's key role today in science and technology revolutions. Timeline of discoveries and contributions by UC Berkeley scholars. Traditions of Cal: Who was the Angel of Death? What's with the "Big C" up there in the hills — and why is it sometimes green? Who wears Oski's jolly bear head and size 54 yellow sweater? Tours and webcams: Check out what's happening on Sproul Plaza, the campus's true heart. See stunning live views of the Bay Area from the Lawrence Hall of Science's perch in the Berkeley hills. Chancellor and administration: Information on Chancellor Robert Birgeneau, Executive Vice Chancellor and Provost George W. Breslauer, and how the university is organized. Organizational charts are included. UC System overview and links: On the campuses, laboratories, and medical centers that comprise UC's public educational system, as well as UC's K-12 partnerships, economic impact, and agriculture and environmental resources.

Career History
Partner
Current
Executive Chairman
2009 - Current
Executive Chairman
2009 - Prior

BioCurex, Inc. engages in the business of developing, producing, marketing and licensing products based on patented and proprietary technology in the area of cancer diagnostics. It focuses on developing and commercializing products for the early detection, diagnosis, and monitoring the recurrence of cancer. It has developed a blood test that can detect the presence of cancer in humans and animals using a new cancer marker named RECAF. RECAF is a molecule found on most cancer cells, including breast, colon, prostate and lung cancers, but not on normal cells and it also can be used in blood tests to determine if a patient has cancer. The company was founded by Ricardo Moro-Vidal on December 8, 1997 and is headquartered in Richmond, Canada.

Boards & Committees
Executive Chairman
2009 - Current
Member, Board of Directors
Current

13therapeutics is an American private company located in Portland, OR. The firm operates as health and science university. Thomas H. Bruggere is the current CEO of the firm.

Director
1996 - Prior

Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA.

Political Donations
$500
2004

Senator from Oregon

$1,000
1998

Senator from Oregon

$500
1995

Representative from Oregon's 4th Congressional District

Transactions
Details Hidden

Yamhill Valley Vineyards, Inc. raised money in a private placement transaction

Details Hidden

Yamhill Valley Vineyards, Inc. raised money in a private placement transaction

Details Hidden

BioCurex, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Enterprise users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Denis R. Burger. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Denis R. Burger's profile does not indicate a business or promotional relationship of any kind between RelSci and Denis R. Burger.